FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance?
Hepatobiliary Surg Nutr
.
2020 Oct;9(5):661-664.
doi: 10.21037/hbsn.2020.01.05.
Authors
Antonio Saviano
1
2
3
,
Simona Tripon
1
2
,
Thomas F Baumert
1
2
3
4
Affiliations
1
Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Inserm U1110, Strasbourg, France.
2
Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
3
University of Strasbourg, Strasbourg, France.
4
Institut Universitaire de France (IUF), Paris, France.
PMID:
33163519
PMCID:
PMC7603928
DOI:
10.21037/hbsn.2020.01.05
No abstract available
Publication types
Editorial
Comment
Grants and funding
R03 AI131066/AI/NIAID NIH HHS/United States
R21 CA209940/CA/NCI NIH HHS/United States
U19 AI123862/AI/NIAID NIH HHS/United States